Novozymes

Novozymes and Chr. Hansen to Merge

Danish companies Novozymes and Chr. Hansen have agreed to merge, in a move they termed a perfect match that will create a global leader in biosolutions.

Novozymes and Saipem Collaborate on Enzymatic Carbon Capture

Danish biotech Novozymes and Italian engineering company Saipem have agreed to collaborate on the development and commercialization of an enzymatic carbon capture process, a biological alternative to traditional carbon capture.

Novozymes and Novo Nordisk Partner on Enzymes

Danish companies Novozymes and Novo Nordisk Pharmatech are teaming up to develop technical enzymes to support biopharma processing. The companies aim to develop high-quality enzymatic processing aids for the regenerative medicines market, focusing on stem cell and gene therapies.

Novozymes and Anuvia Partner on Plant Biotech

Danish biotech Novozymes has linked up with US-based Anuvia Plant Nutrients to develop a range of combined biotechnologies to reduce the need for synthetic fertilizers in commercial agriculture. As a first step, the companies will combine Novozymes’ phosphate solubilizing microbial solutions with Anuvia’s bio-based fertilizer products to enhance macronutrient efficiency with a focus on phosphate.

Novozymes Boosts Microbiome with Biota Buy

Novozymes has acquired Biota’s microbiome R&D team and data science platform for an undisclosed sum. The move builds on two previous deals in the microbiome field this past year, notably of US-based Microbiome Labs and Ireland’s PrecisionBiotics.

Novozymes and FMC Link on Biological Pest Control

Danish biotech Novozymes has announced a collaboration with US agricultural sciences group FMC to research, develop and commercialize biological enzyme-based crop protection solutions. The move is part of Novozymes’ entry into the biocontrol segment, using its new enzyme-based technology.

Novozymes Buys Microbiome Labs

Novozymes is to buy US-based Microbiome Labs, strengthening the Danish biotech’s presence in probiotics and gaining entry into the important North American market. The transaction is expected to close in the first half of January 2021.

Novozymes Boosts Gut Health with PrecisionBiotics

Danish biotech Novozymes has acquired Ireland’s PrecisionBiotics Group for €80 million on a cash and debt-free basis.

Syngenta and Novozymes Win Taegro Approvals

After more than seven years of collaboration, Syngenta and Novozymes are now entering the commercialization phase of their microbial-based foliar fungicide Taegro.

Marquis Sues Novozymes on Trade Secrets

Novozymes and Green Plains Partner on Proteins

Carbios and Novozymes in Enzymes Deal

Novozymes and Attis in Ethanol Pact

The BioAg Alliance Readies New Seed Coatings, Plans Expansion into Europe

Novozymes Expands Enzymes in India

Novozymes Separates Biopharma Activities

Reinventing Sustainable Value Creation

BASF Quits R&D Pact With Novozymes and Cargill

Bio-based Acrylic Acid Milestone for BASF, Cargill and Novozymes

AOCS World Conference on Fabric and Home Care

Novozymes Increases 2014 Profit Outlook

Novozymes Biopharma Announces Collaboration with Janssen to Evaluate Proprietary Veltis Half-Life Extension Technology

Duloxetine: Refining its Chemical Synthesis with Biocatalysis

Novozymes: Producing More with Fewer Resources

Novozymes Acquires Enzyme Business from Canadian Iogen

Novozymes Biopharma Announces Research Agreement with EpiVax

Novozymes Says Efficiency Boost to Keep Margins High

Cheap Shale Gas Gives Impetus to Bioplastics Growth

Novozymes Develops Fungus to Produce Biochemicals

Recombinant Human Albumin

Novozymes Now Supplying Pharmaceutical Grade Q7 cGMP Hyaluronic Acid

Syngenta, Novozymes to Partner for Phosphate Use Efficiency

Novozymes Shares Drop After Q4 Profit Misses Forecast

Functional Ingredients

Chemical Industry R&D Cooperation in China